Potassium Sparing Diuretics (Aldosterone antagonists)
Drug Safety Update
December 2016: caution when co-prescribing with ACE inhibitors or Angiotensin II receptor antagonists increased risk of hyperkalaemia
NICE Guidance (see drug-specific link below)
Finerenone is an option for treating stage 3 and 4 CKD (with albuminuria) associated with type 2 diabetes in adults when prescribed according to NICE TA877. It is for specialist initiation by nephrologist/part of EKHUFT renal centre
Oral solution only to be used for swallowing difficulties. Avoid switching formulations as solution is not bioequivalent to tablets. If a switch is necessary, caution and increased clinical supervision are required.
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| 500 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| 20 tablet |
| 28 tablet |
| 30 tablet |
| 60 tablet |
| Pack |
|---|
| 1 ml |
| 20 ml |
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary